Diffuse Large Cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-07-31
Clinical Trial Update: Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL [Phase 2]
Phase 2 trial evaluating belinostat combined with Yttrium-90 ibritumomab tiuxetan in relapsed aggressive B-cell non-Hodgkin lymphoma has com…